SAN DIEGO (AP) — SAN DIEGO (AP) — Arcturus Therapeutics (ARCT) on Monday reported a loss of $14.1 million in its first quarter.
On a per-share basis, the San Diego-based company said it had a loss of 52 cents.
The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of $1.58 per share.
The pharmaceutical company posted revenue of $29.4 million in the period.
Arcturus Therapeutics shares have fallen 32% since the beginning of the year. In the final minutes of trading on Monday, shares hit $11.60, a drop of 57% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ARCT at https://www.zacks.com/ap/ARCT
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
